Health Care & Life Sciences » Pharmaceuticals | Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

Hebei Changshan Biochemical Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
700
807
911
1,105
1,399
1,628
Cost of Goods Sold (COGS) incl. D&A
319
349
318
409
507
494
Gross Income
381
459
593
696
893
1,134
SG&A Expense
233
283
385
467
636
853
EBIT
146
173
204
231
257
280
Non Operating Income/Expense
3
1
3
3
7
2
Interest Expense
17
28
33
30
31
46
Pretax Income
135
157
186
204
238
171
Income Tax
20
23
29
26
36
39
Equity in Affiliates
-
-
-
-
-
-
Consolidated Net Income
115
134
157
178
202
132
Net Income
115
134
156
175
197
140
Net Income After Extraordinaries
115
134
156
175
197
140
Net Income Available to Common
115
134
156
175
197
140
EPS (Basic)
0.14
0.16
0.18
0.20
0.21
0.15
Basic Shares Outstanding
848
848
848
877
935
935
EPS (Diluted)
0.14
0.16
0.18
0.20
0.21
0.15
Diluted Shares Outstanding
848
848
848
877
935
935
EBITDA
163
201
235
265
299
326
Other Operating Expense
2
3
4
1
-
-
Non-Operating Interest Income
7
1
1
2
6
6
Minority Interest Expense
-
1
1
3
5
8

About Hebei Changshan Biochemical Pharmaceutical Co.

View Profile
Address
North End of Yinchuan Avenue
Shijiazhuang Hebei 050800
China
Employees -
Website http://www.heparin.cn
Updated 07/08/2019
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of heparin active pharmaceutical ingredient (API) and heparin preparations. Its products include heparin raw materials, heparin sodium injection, enoxaparin sodium API, heparin sodium raw materials, low molecular weight heparin calcium drug, enoxaparin sodium injection, and low molecular weight heparin calcium injection. The company was founded on September 28, 2000 and is headquartered in Shijiazhuang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.